Tripping Me Out — Genetically Engineered Psychedelics

🧪🌿 The Franken-Plant That Makes Five Psychedelics at Once

Hey there,

You know those sci-fi stories where mad scientists brew something wild in a lab? This one just stepped out of the pages of Science Advances and into reality.

A team at Israel’s Weizmann Institute of Science (led by Asaph Aharoni and Paula Berman) has genetically engineered a tobacco relative—Nicotiana benthamiana, the trusty lab workhorse of plant biology—to simultaneously produce five powerful psychedelic tryptamines:

• DMT (the “spirit molecule” from ayahuasca plants)
• Psilocybin and its active form psilocin (from magic mushrooms)
• Bufotenin and 5-MeO-DMT (compounds linked to the Sonoran Desert toad)

They did it by reconstructing biosynthetic pathways from three different kingdoms of life—plants, fungi, and animals—then inserting nine key genes into the tobacco plant using a technique called agroinfiltration.

A bacterium delivers the genes temporarily, the plant’s own machinery (starting from the amino acid tryptophan) does the rest, and after a few weeks of growth, the leaves contain all five compounds.

It’s not about growing a backyard trip garden (yields vary because the pathways compete for the same building blocks). Instead, this is a proof-of-concept for sustainable, scalable production of these molecules.

No more over-harvesting vulnerable plants or stressing toad populations. No messy chemical synthesis. Just a fast-growing plant that could one day act as a biological factory for research-grade psychedelics.

The researchers even used advanced protein modeling to design a mutant enzyme that boosted production of one compound up to 40-fold in some setups. They also created new-to-nature analogs that might have unique therapeutic profiles.

Why This Matters

Psychedelic-assisted therapy is gaining serious traction for conditions like depression, PTSD, and anxiety. But supply bottlenecks and ecological concerns have been real hurdles.

A plant-based platform like this could ease those pressures while opening the door to new analogs and more accessible research.

As one of the authors put it, combining five psychedelics in one system is something “no one has ever tried.” Pure science fiction… until it wasn’t.

The paper dropped April 1, 2026, in Science Advances (no, it wasn’t an April Fool’s joke).

What do you think—coolest biotech flex of the year, or are we one step closer to psychedelic salad?

Reply and let me know. Or hit forward if someone in your circle would geek out over this.

Shane DFWSAS

P.S. One researcher already joked about future “psychedelic microdosing tomatoes.” We’ll see how far synthetic biology takes us.